1 / 5

Extension of CDSCO WHO’s GMP certificate

India is increasing the validity of the World Health Organisation(WHO) Good Manufacturing Practices (GMP) certificate to three years.<br>Contact details u2013 <br>Phone no - 9325283428<br>Mail - dm@operonstrategist.com<br>Visit u2013 https://www.operonstrategist.com/cdsco-whos-gmp-certificate/#utm_source=PPT & PDF submission&utm_medium=PPT & PDFpage&utm_campaign=PPT & PDF submission<br>

operon
Télécharger la présentation

Extension of CDSCO WHO’s GMP certificate

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Extension of CDSCO WHO’s GMP certificate Call / Whatsapp - 9325283428 www.operonstrategist.com

  2. In a move to improve ease of doing business, India is increasing the validity of the World Health Organisation(WHO) Good Manufacturing Practices (GMP) certificate to three years. The CDSCO WHO GMP certificate was earlier valid for two years, said Drug Controller General of India Eswara Reddy during the 6th annual International Exhibition of Pharma and Healthcare (iPHEX) on Tuesday. • The measure would also result in more product registration for exports, he said, adding that a key demand of the industry has been met. Call / Whatsapp - 9325283428 www.operonstrategist.com

  3. Likewise, the protocol for clinical trial approvals has also been changed by setting the timeline of approval at 45 days. Once approval does not come within this timeline, the protocol would be deemed to be approved. • Government is committed to promoting pharmaceutical exports to untapped markets, including China which has agreed for a high-level bilateral roundtable to pave way for Indian pharma to get market access and penetration in their market, commerce and industry minister Suresh Prabhu said during iPHEX. Call / Whatsapp - 9325283428 www.operonstrategist.com

  4. The US accounts for over 30% of India’s $17.25 billion pharma exports and India has the highest number of US FDA approved plants outside the US, according to data from the Pharmaceutical Export Promotion Council (PHARMEXCIL). • “Effort is on to ensure uniform quality. We take it very seriously and want to ensure that consistent quality and efficacy come out of the Indian products,” added commerce secretary Rita Teotia. • The size of the Indian pharmaceutical industry is expected to increase to $50 billion in the next few years from the present size of $32-33 billion, according to PHARMEXCIL chairman Madan Mohan Reddy. Call / Whatsapp - 9325283428 www.operonstrategist.com

  5. Thank You. For More Information Contact Us info@operonstrategist.com Call / Whatsapp - 9325283428 www.operonstrategist.com

More Related